Q32 Bio (QTTB) Cash from Investing Activities (2017 - 2025)

Q32 Bio's Cash from Investing Activities history runs 9 years deep, the most recent figure standing at $7.0 million for Q4 2025.

• On a quarterly basis, Cash from Investing Activities rose 350100.0% year-over-year to $7.0 million in Q4 2025; TTM through Mar 2026 was $7.0 million, a 64.7% decrease from a year earlier, with the FY2025 full-year figure at $7.0 million, down 64.87% from the prior year.
• Cash from Investing Activities rose to $7.0 million in Q4 2025 per QTTB's latest filing, from -$2000.0 in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $168.3 million in Q1 2022 and bottomed at -$108.2 million in Q3 2022.
• The 5-year median for Cash from Investing Activities is $49000.0 (2023), against an average of $803000.0.
• Across the five-year window, Cash from Investing Activities tumbled 2492.09% in 2022 and surged 994300.0% in 2024, its largest moves.
• Year by year, Cash from Investing Activities stood at $43.7 million in 2021, then sank by 58.79% to $18.0 million in 2022, then sank by 100.01% to -$1000.0 in 2023, then plunged by 100.0% to -$2000.0 in 2024, then jumped by 350100.0% to $7.0 million in 2025.
• Per Business Quant, the three latest QTTB Cash from Investing Activities figures stand at $7.0 million (Q4 2025), -$2000.0 (Q4 2024), and $9.9 million (Q3 2024).